World Congress on Brain & Endocrinologists

Dear Attendees,

After the successful completion of the first & second series, Medical Conferences 2025. We, Times Scientific Group are delighted to invite you to the World Congress on Brain & Endocrinologists, scheduled during on December 03-04, 2026 in Osaka, Japan.

World Brain & Endocrine 2026 conference will bring together leading Scientists, Scholars, Expert Surgeons, Doctors, Practitioners, researchers, and healthcare professionals from across the globe to share ground-breaking research, innovative practices, and the latest developments in Brain and Endocrine System. Our goal is to share the latest scientific discoveries, clinical practices, and innovations, and to foster collaboration that advances Brain and Endocrine System.

Recent years have seen remarkable progress in Brain and Endocrine system, driven by innovations in genomics, Artificial Intelligence, Tele-medicine, and precision care. Key Sessions include the development of personalized paediatric vaccines, early diagnostic tools for congenital and genetic disorders, AI-assisted imaging for paediatric cardiology and oncology, minimally invasive neonatal surgery, and interventions targeting childhood obesity and metabolic disorders.

Advances in neonatal intensive care, such as precision nutrition, non-invasive respiratory support, and innovative pharmacological therapies, are transforming outcomes for preterm and critically ill infants. Emerging research areas like spatial transcriptomics in paediatric diseases, stem-cell therapies, paediatric immuno-therapy, and AI-based early intervention programs are paving the way for the next generation of paediatric care.

Asia has been at the forefront of international collaborative research in the Brain and Endocrine system, with countries like Japan, South Korea, and China contributing to large-scale neuroendocrine studies, hormonal disorder surveillance, and genetic research initiatives. Japanese institutions, have developed advanced Brain and Endocrine system screening programs and integrated healthcare models that enhance early detection and improve outcomes for high-risk individuals with neurological and endocrine disorders.

Why Attend / Key Highlights:

By joining the Euro Brain and Endocrinologists 2026 Conference, you will:
• Attend Plenary Lectures delivered by leading international and national experts in brain and endocrine research.
• Participate in Poster Sessions and compete for Young Researcher Awards.
• Explore an Exhibition showcasing the latest neuroendocrine technologies, diagnostic tools, and therapeutic innovations.
• Engage in Networking Opportunities with clinicians, neuroscientists, endocrinologists, researchers, and industry professionals.
• Gain insights into the latest clinical practices, translational research, and technological advancements shaping the future of brain and endocrine science.

Why Osaka, Japan?

Osaka is more than a host city — it is a dynamic center of medical innovation, scientific research, and global collaboration. Renowned for its strong academic and clinical foundation, Osaka is home to prestigious institutions such as Osaka University, National Cerebral and Cardiovascular Center, and several leading endocrine, neuroscience, and translational research hubs that contribute significantly to advancements in brain and endocrine sciences.

As one of Japan’s foremost medical and biotechnology centers, Osaka promotes interdisciplinary research and international collaboration through its extensive network of universities, teaching hospitals, and research-driven industries. The city’s commitment to cutting-edge healthcare technologies, precision medicine, and clinical excellence makes it an ideal platform for high-impact scientific dialogue.

With excellent global accessibility, a thriving academic community, and a distinctive culture known for its openness and innovation, Osaka offers a welcoming and stimulating environment for researchers and clinicians alike. Blending scientific progress with rich cultural heritage and modern infrastructure, Osaka provides exceptional opportunities for professional development, collaboration, and discovery—making it a compelling and inspiring venue for the Euro Brain and Endocrinologists 2026 Conference.

Visa & Travel Assistance:

All registered international participants will receive an official invitation letter to get their visa application. We recommend submitting applications early to ensure timely processing and smooth travel. Register early for the conference to secure your spot and enjoy all sessions, networking opportunities, and conference benefits without any hassle.

Brain and Endocrinologists Market Analysis in the US, Europe & Asia for 2024–2025:

United States

• Market Share: The U.S. held approximately 40% of the global neuroendocrinology and brain health market in 2024 (Precedence Research).
• Forecast: The neuroendocrine and brain therapeutics market is projected to reach USD 18.5 billion by 2032, growing at a 5.2% CAGR (Grand View Research).
• Key Drivers: Rising prevalence of neurodegenerative and endocrine disorders, rapid adoption of AI-driven diagnostics, and strong investment in biotech and clinical research.

Europe
• Market Dynamics: Europe accounted for 30% of the global brain and endocrine therapeutics market in 2024 (Fortune Business Insights).
• Growth Factors: Increasing focus on integrated neuroendocrine research, expansion of precision medicine, and robust collaborations among universities and pharmaceutical companies.
• Leading Countries: Germany, the Netherlands, and the UK lead the region with major advancements in neuroscience, endocrinology, and clinical trials.

Asia-Pacific

• Market Growth: The Asia-Pacific region is projected to register the fastest CAGR (6.5%) between 2024 and 2030 (Strategic Market Research).
• Key Markets: Japan, China, and South Korea are driving growth with large-scale neuroendocrine research programs, increased healthcare investments, and adoption of AI-based screening technologies.
• Emerging Trends: Growing focus on aging populations, metabolic and hormonal disorders, and innovative brain-endocrine healthcare models contribute to sustained market expansion.

Join us in Osaka, Japan to connect with global experts, share pioneering research, and explore innovations shaping the future of brain and endocrine science.

•    ENT Manifestations of Endocrine Disorders
•    Neuroendocrine Mechanisms in Tinnitus and Hearing Loss
•    Hypothalamic–Pituitary Axis and Cognitive Function
•    Neuroendocrine Control of Emotions and Behavior
•    Hormonal Influence on Sleep, Mood, and Perception
•    Stress Hormones and Neural Plasticity
•    Neuroendocrine Pathways in Depression, Anxiety, and Fatigue
•    Cortisol and Its Impact on Sensory and Cognitive Health
•    Hormonal Regulation of Brain Rhythms and Sensory Integration
•    Neurobehavioral Endocrinology: How Hormones Shape Perception
•    Thyroid Disorders and ENT Manifestations
•    Pituitary Tumors Presenting with ENT Symptoms
•    Endocrine Aspects of Nasal and Sinus Disease
•    ENT Complications of Hormone Therapy
•    Parathyroid and Calcium Disorders Affecting Ear and Skull Bones
•    Hormonal Regulation of Salivary Glands and Taste Function
•    ENT Involvement in Neuroendocrine Tumors (Head and Neck NETs)
•    Neuroendocrine Signaling Pathways in Sensory Neurons
•    Molecular Crosstalk Between Hormones and Neurotransmitters
•    Brain Imaging in Neuroendocrine and ENT Disorders
•    Biomarkers Linking Hormonal Imbalance and Neural Dysfunction
•    Precision Medicine in Neuroendocrine–ENT Disorders
•    Artificial Intelligence in Neuroendocrine and ENT Diagnostics
•    Digital Biomonitoring of Hormonal and Sensory Function
•    Personalized Hormone Therapy and Brain Health
•    Neuroendocrine Aging and Sensory Decline
•    Brain–Gut–ENT Axis: Hormones, Inflammation, and Perception
•    Integrative Neuroendocrine Rehabilitation for Sensory Disorders

•    Neuro Surgeons, Neuro Doctors, Endocrinologists
•    Neuropsychologist, Psychiatrist, Neuro-ophthalmologist
•    Neuroscientist, Professor (Assistant / Associate / Full)
•    Pediatric Neurologist, Neuro-oncologist, Endocrinologist, Otorhinolaryngologist
•    Pediatric Endocrinologist, Diabetologist, Clinical Pharmacist
•    Reproductive Endocrinologist, Thyroid Specialist, Clinical Pharmacist
•    Neurorehabilitation Therapist, Neurology Nurse, Endocrine Nurse
•    Endocrine Researcher / Scientist, Medical Lab Technologist
•    Neuro & Endocrine
•    Post-Graduate students, Post-doctoral fellows
•    Young researchers, Scientists
•    Business Delegates
•    Public Health Experts and Policy Makers
•    Researchers, Medical Students, Training Institutes and Industry
•    Professionals
•    Industry professionals in medical devices, pharmaceuticals, diagnostics
•    Healthcare Professionals from Other Disciplines
 

Only Registration Fee includes (Academic, Business & Students)

Free access to all lectures in single event
Tea & Coffee break during the event dates
Lunch during the conference
Abstract book & Event gadgets
Single complimentary paper abstract (For Speakers & Poster's)
Certificate of Presentation

For registration please click Slot Booking

Brain and Endocrinologists Market Analysis in the US, Europe & Asia for 2024–2025:

United States
• Market Share: The U.S. held approximately 40% of the global neuroendocrinology and brain health market in 2024 (Precedence Research).
• Forecast: The neuroendocrine and brain therapeutics market is projected to reach USD 18.5 billion by 2032, growing at a 5.2% CAGR (Grand View Research).
• Key Drivers: Rising prevalence of neurodegenerative and endocrine disorders, rapid adoption of AI-driven diagnostics, and strong investment in biotech and clinical research.

Europe
• Market Dynamics: Europe accounted for 30% of the global brain and endocrine therapeutics market in 2024 (Fortune Business Insights).
• Growth Factors: Increasing focus on integrated neuroendocrine research, expansion of precision medicine, and robust collaborations among universities and pharmaceutical companies.
• Leading Countries: Germany, the Netherlands, and the UK lead the region with major advancements in neuroscience, endocrinology, and clinical trials.

Asia-Pacific
• Market Growth: The Asia-Pacific region is projected to register the fastest CAGR (6.5%) between 2024 and 2030 (Strategic Market Research).
• Key Markets: Japan, China, and South Korea are driving growth with large-scale neuroendocrine research programs, increased healthcare investments, and adoption of AI-based screening technologies.
• Emerging Trends: Growing focus on aging populations, metabolic and hormonal disorders, and innovative brain-endocrine healthcare models contribute to sustained market expansion.